Company profile for Suzhou GenAssist Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Suzhou GenAssist Therapeutics Co., Ltd., was founded by outstanding scientist and industry expert in July 2020. We are committed to the development of gene editing drugs for a variety of genetic diseases. GenAssist owns global intellectual property rights of TAM (Targeted AID-based Mutagenesis) base editing technology. Our therapeutic focus is neuromuscular diseases without effective therapy, including DMD and SMA. By precisel...
Suzhou GenAssist Therapeutics Co., Ltd., was founded by outstanding scientist and industry expert in July 2020. We are committed to the development of gene editing drugs for a variety of genetic diseases. GenAssist owns global intellectual property rights of TAM (Targeted AID-based Mutagenesis) base editing technology. Our therapeutic focus is neuromuscular diseases without effective therapy, including DMD and SMA. By precisely repairing disease-causing genes in situ, gene editing technology is expected to bring permanent cure for many human diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Unit E395, North Block, Building A1, Biomedical Industrial Park No. 218 Xinghu...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/genassist-ltd-announces-fda-clearance-of-investigational-new-drug-application-for-gen6050x-a-globally-first-in-class-base-editing-drug-for-duchenne-muscular-dystrophy-302394445.html

PR NEWSWIRE
06 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty